# Acurx Pharmaceuticals, Inc.: filings

ACXP · Nasdaq · CIK 1736243 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/acxp.md) · [Financials](/companies/acxp/financials.md) · [Filings](/companies/acxp/filings.md) · [Insiders](/companies/acxp/insiders.md)

## Reports and events: 82 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 51, 8-K 38, 10-Q 16, CORRESP 14, EFFECT 14, S-1 13, UPLOAD 13, 424B3 10, 3 8, D 7, 424B5 6, DEF 14A 6, DEFA14A 6, S-8 6, 10-K 5, ARS 4, D/A 3, PRE 14A 3, FWP 2, S-1/A 2, S-3 2, SC 13D 2, SC 13G 2, 424B4 1, 8-A12B 1, CERT 1, DRS 1, DRS/A 1, DRSLTR 1, POS AM 1, RW 1, S-3/A 1, SC 13G/A 1, SCHEDULE 13G 1, SCHEDULE 13G/A 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-29 | 17:20 ET | [8-K](/filings/0001104659-26-120279.md) | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001104659-26-120279 |
| 2026-10-16 | 16:30 ET | [8-K](/filings/0001104659-26-116632.md) | 5.07 Shareholder vote results | 0001104659-26-116632 |
| 2026-09-08 | 16:27 ET | [S-1](/filings/0001104659-26-105917.md) | Registration statement | 0001104659-26-105917 |
| 2026-09-01 | 16:15 ET | [DEF 14A](/filings/0001104659-26-104316.md) | Proxy statement, period 2026-10-16 | 0001104659-26-104316 |
| 2026-08-13 | 16:07 ET | [10-Q](/filings/0001104659-26-095904.md) | Quarterly report, period 2026-06-30 | 0001104659-26-095904 |
| 2026-05-11 | 16:05 ET | [10-Q](/filings/0001104659-26-058631.md) | Quarterly report, period 2026-03-31 | 0001104659-26-058631 |
| 2026-05-04 | 16:09 ET | [S-1](/filings/0001104659-26-054887.md) | Registration statement | 0001104659-26-054887 |
| 2026-05-04 | 16:08 ET | [S-1](/filings/0001104659-26-054884.md) | Registration statement | 0001104659-26-054884 |
| 2026-04-16 | 08:14 ET | [8-K](/filings/0001104659-26-044093.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-044093 |
| 2026-03-12 | 16:06 ET | [10-K](/filings/0001104659-26-027052.md) | Annual report, period 2025-12-31 | 0001104659-26-027052 |
| 2026-03-09 | 08:59 ET | [8-K](/filings/0001104659-26-025003.md) | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-025003 |
| 2026-02-02 | 16:48 ET | [S-1](/filings/0001104659-26-009266.md) | Registration statement | 0001104659-26-009266 |
| 2025-11-12 | 07:00 ET | [10-Q](/filings/0001104659-25-109698.md) | Quarterly report, period 2025-09-30 | 0001104659-25-109698 |
| 2025-10-20 | 16:01 ET | [S-1](/filings/0001104659-25-100800.md) | Registration statement | 0001104659-25-100800 |
| 2025-09-22 | 16:42 ET | [8-K](/filings/0001104659-25-092166.md) | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001104659-25-092166 |
| 2025-09-19 | 17:16 ET | [8-K](/filings/0001104659-25-091733.md) | 5.07 Shareholder vote results | 0001104659-25-091733 |
| 2025-08-11 | 16:05 ET | [10-Q](/filings/0001558370-25-011045.md) | Quarterly report, period 2025-06-30 | 0001558370-25-011045 |
| 2025-08-04 | 09:19 ET | [DEF 14A](/filings/0001104659-25-073623.md) | Proxy statement, period 2025-09-16 | 0001104659-25-073623 |
| 2025-07-31 | 09:29 ET | [8-K](/filings/0001104659-25-072529.md) | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-072529 |
| 2025-07-17 | 16:06 ET | [8-K](/filings/0001104659-25-068659.md) | 5.07 Shareholder vote results | 0001104659-25-068659 |
| 2025-07-15 | 20:22 ET | [S-1](/filings/0001104659-25-067841.md) | Registration statement | 0001104659-25-067841 |
| 2025-06-20 | 08:00 ET | [8-K](/filings/0001104659-25-060902.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-060902 |
| 2025-05-29 | 16:05 ET | [DEF 14A](/filings/0001104659-25-054235.md) | Proxy statement, period 2025-07-17 | 0001104659-25-054235 |
| 2025-05-21 | 16:16 ET | [S-1](/filings/0001104659-25-051615.md) | Registration statement | 0001104659-25-051615 |
| 2025-05-13 | 07:12 ET | [8-K](/filings/0001104659-25-047566.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-047566 |
| 2025-05-12 | 16:05 ET | [10-Q](/filings/0001558370-25-007371.md) | Quarterly report, period 2025-03-31 | 0001558370-25-007371 |
| 2025-05-08 | 16:30 ET | [8-K](/filings/0001104659-25-046167.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001104659-25-046167 |
| 2025-04-04 | 16:02 ET | [S-1](/filings/0001104659-25-032184.md) | Registration statement | 0001104659-25-032184 |
| 2025-03-28 | 16:10 ET | [8-K](/filings/0001104659-25-029370.md) | 3.01 Delisting notice | 0001104659-25-029370 |
| 2025-03-18 | 07:12 ET | [8-K](/filings/0001104659-25-024731.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-024731 |
| 2025-03-17 | 16:05 ET | [10-K](/filings/0001558370-25-003117.md) | Annual report, period 2024-12-31 | 0001558370-25-003117 |
| 2025-03-10 | 07:35 ET | [8-K](/filings/0001104659-25-021978.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-021978 |
| 2025-02-26 | 16:10 ET | [8-K](/filings/0001104659-25-017437.md) | 3.01 Delisting notice | 0001104659-25-017437 |
| 2025-01-31 | 16:11 ET | [S-1](/filings/0001410578-25-000067.md) | Registration statement | 0001410578-25-000067 |
| 2025-01-07 | 10:00 ET | [8-K](/filings/0001104659-25-001586.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-001586 |
| 2024-11-13 | 07:06 ET | [8-K](/filings/0001104659-24-117214.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-24-117214 |
| 2024-11-12 | 16:05 ET | [10-Q](/filings/0001558370-24-015310.md) | Quarterly report, period 2024-09-30 | 0001558370-24-015310 |
| 2024-08-09 | 07:13 ET | [8-K](/filings/0001104659-24-087545.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-24-087545 |
| 2024-08-08 | 16:05 ET | [10-Q](/filings/0001558370-24-011587.md) | Quarterly report, period 2024-06-30 | 0001558370-24-011587 |
| 2024-06-17 | 16:14 ET | [8-K](/filings/0001104659-24-072270.md) | 5.07 Shareholder vote results | 0001104659-24-072270 |
| 2024-05-15 | 07:13 ET | [8-K](/filings/0001104659-24-061579.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-24-061579 |
| 2024-05-14 | 16:05 ET | [10-Q](/filings/0001558370-24-008130.md) | Quarterly report, period 2024-03-31 | 0001558370-24-008130 |
| 2024-04-29 | 16:07 ET | [DEF 14A](/filings/0001104659-24-054014.md) | Proxy statement, period 2024-06-17 | 0001104659-24-054014 |
| 2024-03-29 | 16:58 ET | [S-1/A](/filings/0001104659-24-041187.md) | Registration statement, amended | 0001104659-24-041187 |
| 2024-03-18 | 16:15 ET | [8-K](/filings/0001104659-24-035556.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-24-035556 |
| 2024-03-18 | 16:06 ET | [S-1](/filings/0001104659-24-035527.md) | Registration statement | 0001104659-24-035527 |
| 2024-03-15 | 16:05 ET | [10-K](/filings/0001558370-24-003401.md) | Annual report, period 2023-12-31 | 0001558370-24-003401 |
| 2023-11-15 | 17:02 ET | [8-K](/filings/0001104659-23-118749.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001104659-23-118749 |
| 2023-11-14 | 16:05 ET | [8-K](/filings/0001104659-23-118064.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-23-118064 |
| 2023-11-13 | 16:05 ET | [10-Q](/filings/0001558370-23-018824.md) | Quarterly report, period 2023-09-30 | 0001558370-23-018824 |

Page 1 of 2. [Older](/companies/acxp/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 29, 2026, 17:22 ET. No prices; not investment advice.